Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV).

Name: Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV).
Author: Brown, Ashley N

Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV). — المؤلف: Brown, Ashley N — Scientific reports 20190701

المؤلف: Brown, Ashley N
النشر: Scientific reports 20190701
الوصف: 14421 p.
الموضوعات: Antiviral Agents؛ Benzimidazoles؛ Cell Line؛ Combined Modality Therapy؛ Drug Interactions؛ Drug Resistance, Viral؛ Drug Therapy, Combination؛ Fluorenes